{
     "PMID": "21889339",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20120118",
     "LR": "20110920",
     "IS": "1464-3405 (Electronic) 0960-894X (Linking)",
     "VI": "21",
     "IP": "20",
     "DP": "2011 Oct 15",
     "TI": "Benzotriazinone and benzopyrimidinone derivatives as potent positive allosteric AMPA receptor modulators.",
     "PG": "6170-5",
     "LID": "10.1016/j.bmcl.2011.07.098 [doi]",
     "AB": "AMPA receptors (AMPARs) have been demonstrated to be an important therapeutic CNS target. A series of substituted benzotriazinone and benzopyrimidinone derivatives were prepared with the aim to improve in vivo activity over the previously reported bis-benzoxazinone based AMPAKINE series from our laboratory. These compounds were shown to be potent, positive allosteric AMPAR modulators that have better in vivo activity and improved metabolic stability over the analogous benzoxazinone derivatives.",
     "CI": [
          "Copyright (c) 2011 Elsevier Ltd. All rights reserved."
     ],
     "FAU": [
          "Mueller, Rudolf",
          "Rachwal, Stanislaw",
          "Lee, Steven",
          "Zhong, Sheng",
          "Li, Yong-Xin",
          "Haroldsen, Peter",
          "Herbst, Todd",
          "Tanimura, Susan",
          "Varney, Mark",
          "Johnson, Steven",
          "Rogers, Gary",
          "Street, Leslie J"
     ],
     "AU": [
          "Mueller R",
          "Rachwal S",
          "Lee S",
          "Zhong S",
          "Li YX",
          "Haroldsen P",
          "Herbst T",
          "Tanimura S",
          "Varney M",
          "Johnson S",
          "Rogers G",
          "Street LJ"
     ],
     "AD": "Cortex Pharmaceuticals Inc., 15231 Barranca Parkway, Irvine, CA 92618, USA. rudolfmueller@yahoo.com",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20110812",
     "PL": "England",
     "TA": "Bioorg Med Chem Lett",
     "JT": "Bioorganic & medicinal chemistry letters",
     "JID": "9107377",
     "RN": [
          "0 (Pyrimidinones)",
          "0 (Receptors, AMPA)",
          "0 (Triazines)"
     ],
     "SB": "IM",
     "MH": [
          "Allosteric Regulation",
          "Animals",
          "Drug Design",
          "Hippocampus/drug effects",
          "Humans",
          "Pyrimidinones/*chemistry/*pharmacology",
          "Rats",
          "Receptors, AMPA/*metabolism",
          "Structure-Activity Relationship",
          "Triazines/*chemistry/*pharmacology"
     ],
     "EDAT": "2011/09/06 06:00",
     "MHDA": "2012/01/19 06:00",
     "CRDT": [
          "2011/09/06 06:00"
     ],
     "PHST": [
          "2011/06/16 00:00 [received]",
          "2011/07/25 00:00 [revised]",
          "2011/07/26 00:00 [accepted]",
          "2011/09/06 06:00 [entrez]",
          "2011/09/06 06:00 [pubmed]",
          "2012/01/19 06:00 [medline]"
     ],
     "AID": [
          "S0960-894X(11)01044-4 [pii]",
          "10.1016/j.bmcl.2011.07.098 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Bioorg Med Chem Lett. 2011 Oct 15;21(20):6170-5. doi: 10.1016/j.bmcl.2011.07.098. Epub 2011 Aug 12.",
     "term": "hippocampus"
}